Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 100951-101000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04340843
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
PHASE2Active, not recruiting
19 participants
Started: Sep 8, 2020 · Completed: Jun 17, 2026
3 conditions1 sponsor39 locations
NCT04875728
The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma
PHASE1Active, not recruiting
20 participants
Started: Sep 8, 2020 · Completed: Feb 2, 2027
14 conditions2 sponsors1 location
NCT04304651
Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism
NARecruiting
1,276 participants
Started: Sep 8, 2020 · Completed: Sep 8, 2030
1 condition4 sponsors20 locations
NCT04548830
Safety of Lung Cryobiopsy in People With Cancer
PHASE2Active, not recruiting
100 participants
Started: Sep 8, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04653740
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
NAActive, not recruiting
25 participants
Started: Sep 8, 2020 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04457258
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
EARLY_PHASE1Active, not recruiting
18 participants
Started: Sep 8, 2020 · Completed: Jul 21, 2027
3 conditions2 sponsors1 location
NCT04242134
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
NAActive, not recruiting
784 participants
Started: Sep 8, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04986748
Using QPOP to Predict Treatment for Sarcomas and Melanomas
N/ARecruiting
100 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT04608032
Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
NARecruiting
70 participants
Started: Sep 8, 2020 · Completed: Dec 1, 2024
1 condition1 sponsor2 locations
NCT04511234
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
NARecruiting
279 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor20 locations
NCT06187454
Transcranial Direct Current Stimulation for Depression
NARecruiting
30 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04390737
Evaluate the Safety and Clinical Activity of HH2853
PHASE1/PHASE2Recruiting
254 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor25 locations
NCT04547543
Follow-up of Apneic Patients by Visio-consultation
NARecruiting
250 participants
Started: Sep 8, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT04699734
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
NARecruiting
16 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05395533
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
PHASE1Active, not recruiting
147 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT04535479
Dry Needling for Spasticity in Stroke
NAActive, not recruiting
32 participants
Started: Sep 8, 2020 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04494009
PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy
PHASE2Active, not recruiting
110 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04226339
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment
NARecruiting
104 participants
Started: Sep 7, 2020 · Completed: Mar 7, 2029
1 condition1 sponsor1 location
NCT04525950
Robotized Navigation Compared to Conventional Technique in Total Knee Replacement
NAActive, not recruiting
214 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2031
2 conditions3 sponsors2 locations
NCT05304988
Development and Validation of the EFT for Adolescents With Cancer
N/ARecruiting
400 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04547309
Research for the Molecular Imaging of the HER2 Targeting Tracer
NARecruiting
200 participants
Started: Sep 7, 2020 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT04121065
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
N/ARecruiting
150 participants
Started: Sep 7, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03597321
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
PHASE2Active, not recruiting
124 participants
Started: Sep 7, 2020 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT04081246
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
NARecruiting
30 participants
Started: Sep 7, 2020 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT04677920
The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology
NAActive, not recruiting
24 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04295538
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
PHASE2Active, not recruiting
60 participants
Started: Sep 6, 2020 · Completed: Jan 31, 2026
1 condition1 sponsor41 locations
NCT04537156
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
PHASE3Active, not recruiting
9,327 participants
Started: Sep 5, 2020 · Completed: Dec 31, 2027
3 conditions3 sponsors2 locations
NCT04167527
Endovascular Therapy for Low NIHSS Ischemic Strokes
PHASE2/PHASE3Active, not recruiting
143 participants
Started: Sep 5, 2020 · Completed: Sep 30, 2025
1 condition5 sponsors34 locations
NCT04385290
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
PHASE1/PHASE2Recruiting
214 participants
Started: Sep 4, 2020 · Completed: Apr 30, 2028
1 condition3 sponsors21 locations
NCT04310670
Integrated Treatment in FND (Functional Neurological Disorders)
NARecruiting
30 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04159675
Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts
N/ARecruiting
20 participants
Started: Sep 4, 2020 · Completed: Apr 4, 2026
1 condition1 sponsor1 location
NCT04258137
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NARecruiting
332 participants
Started: Sep 4, 2020 · Completed: Dec 1, 2027
2 conditions1 sponsor6 locations
NCT04195347
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT04387916
A Study of KC1036 in Patients with Advanced Solid Tumors
PHASE1Recruiting
207 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT04550442
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Sep 4, 2020 · Completed: Oct 31, 2025
5 conditions3 sponsors1 location
NCT05266144
Atrial Fibrillation Patients Treated With Catheter Ablation
N/ARecruiting
300 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04541056
Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae
NAActive, not recruiting
60 participants
Started: Sep 4, 2020 · Completed: Feb 28, 2026
3 conditions4 sponsors3 locations
NCT04355689
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Sep 3, 2020 · Completed: Aug 31, 2025
1 condition2 sponsors4 locations
NCT05478876
Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract
NARecruiting
9 participants
Started: Sep 3, 2020 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT04554927
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
NARecruiting
438 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04353375
Phase 2 Study of HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
PHASE2Recruiting
128 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04673955
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
N/ARecruiting
500 participants
Started: Sep 3, 2020 · Completed: Jan 31, 2027
1 condition4 sponsors70 locations
NCT04039763
RT-CGM in Young Adults at Risk of DKA
NARecruiting
20 participants
Started: Sep 3, 2020 · Completed: Jun 30, 2022
6 conditions2 sponsors1 location
NCT03935295
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
PHASE4Recruiting
90 participants
Started: Sep 3, 2020 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04192136
NAD+ and Exercise in FA
NAActive, not recruiting
80 participants
Started: Sep 3, 2020 · Completed: Feb 7, 2026
1 condition2 sponsors1 location
NCT04442022
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2/PHASE3Recruiting
501 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor57 locations
NCT05402085
N=1 Trials of Individual Variability in Post-prandial Glycemic Responses to Diets of Varying Macronutrient Composition
NAActive, not recruiting
120 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04257500
Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/obese Women with PCOS
PHASE4Recruiting
28 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04548817
Neurocutaneous Melanocytosis Registry
N/ARecruiting
100 participants
Started: Sep 3, 2020 · Completed: Sep 3, 2027
3 conditions1 sponsor2 locations
NCT04602468
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
PHASE4Active, not recruiting
237 participants
Started: Sep 3, 2020 · Completed: Jul 1, 2029
5 conditions12 sponsors7 locations